Precision Medicine News and Research

RSS

MGI reveals latest updates at ESHG conference in Glasgow

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, held a Corporate Satellite Meeting and revealed significant local partnerships at the ESHG Conference in Glasgow.

From MGI 16 Jun 2023

Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy Test for the Early Detection of Lung Cancer

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced new data on the development of a screening test for the early detection of lung cancer.

From Owlstone Medical Ltd 15 Jun 2023

Increased risk of T2D in patients linked to low birthweight, study finds

T2D patients with lower birthweight also show higher use of diabetes drugs than those with normal birthweight, and a larger number of comorbidities including high blood pressure, at the time of diagnosis.

13 Jun 2023

New data challenge seeks to unravel how lipoprotein(a) levels impact risk of cardiovascular disease

The American Heart Association, the world's leading voluntary organization focused on heart and brain health, invites scientific researchers across the globe to compete in a new data challenge to better inform the scientific understanding of how lipoprotein(a) [Lp(a)] levels impact the risk of cardiovascular disease and stroke.

12 Jun 2023

Study:Overactive inflammatory response could be at the root of many long COVID cases

An overactive inflammatory response could be at the root of many long COVID cases, according to a new study from the Allen Institute and Fred Hutchinson Cancer Center.

12 Jun 2023

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

Humanigen, Inc.today extended previously reported results by presenting additional, statistically significant hematologic improvements and reductions in inflammatory markers from lenzilumab, its investigational drug, in a Phase 2/3 trial of treatment-naïve participants with chronic myelomonocytic leukemia and RAS-pathway mutations.

9 Jun 2023

Weak spot discovery could pave way for more effective cancer therapies

Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375'000 patients will die from it each year.

8 Jun 2023

Shifting towards precision medicine for type 2 diabetes dietary management

Researchers reviewed existing data on the genetic factors and the gene-diet interactions that could alter dietary management of type 2 diabetes.

8 Jun 2023

AI algorithms outperform the standard clinical risk model for predicting breast cancer risk

In a large study of thousands of mammograms, artificial intelligence (AI) algorithms outperformed the standard clinical risk model for predicting the five-year risk for breast cancer. The results of the study were published in Radiology, a journal of the Radiological Society of North America (RSNA).

6 Jun 2023

SickKids scientists shine light on the complex genetics that underlie blood pressure regulation

Scientists at The Hospital for Sick Children (SickKids) are delving deep into the non-coding genome to unravel the complex genetics that underlie blood pressure regulation and hypertension (high blood pressure) – the leading cause of cardiovascular disease affecting 1.25 billion people worldwide.

6 Jun 2023

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority

Recently, BGI Genomics' COLOTECT 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, Stool Sample Collection Kit have received market authorization from Malaysia's Medical Device Authority (hereinafter referred to as MDA).

6 Jun 2023

Research sheds new light on the genetic architecture of bipolar disorder

Bipolar disorder (BD) is a major psychiatric condition that afflicts about 1% of people. Symptoms of BD include sudden onset of depressive mood with loss of interest which alternates with a manic state of hyperactivity.

5 Jun 2023

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

REPROCELL today announces the launch of a new commercial service, Pharmacology-AI.

From REPROCELL 2 Jun 2023

NCI launches new initiative to test new drug combinations that target specific tumor alterations

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations.

1 Jun 2023

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Over 2,800 cases, representing a 31% increase, added to BGI Genomics-led CardioGen's hereditary cardiovascular disease gene data.

From BGI Genomics 1 Jun 2023

Illinois Tech selected as enrollment site for NIH's landmark initiative to advance nutrition research

Illinois Institute of Technology is one of 14 institutions chosen as an enrollment site for the National Institute of Health's landmark initiative to advance nutrition research.

26 May 2023

Markey one of 71 NCI designated cancer centers in the U.S.

When the University of Kentucky Markey Cancer Center earned a designation the National Cancer Institute (NCI) in 2013, it instantly established Markey as one of the top cancer research centers in the U.S.

26 May 2023

Study examines the role of genetic variants across diverse ancestries in regulating gene expression

Exploring diverse ancestry is a critical factor in furthering medical research.

25 May 2023

Study highlights the genetic basis of cognitive biases in decision making

Have you ever made a decision that, in hindsight, seemed irrational? A new study with mice, which could have implications for people, suggests that some decisions are, to a certain extent, beyond their control.

25 May 2023

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.

24 May 2023

Precision Medicine News and Research

MGI reveals latest updates at ESHG conference in Glasgow

Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy Test for the Early Detection of Lung Cancer

Increased risk of T2D in patients linked to low birthweight, study finds

New data challenge seeks to unravel how lipoprotein(a) levels impact risk of cardiovascular disease

Study:Overactive inflammatory response could be at the root of many long COVID cases

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

Weak spot discovery could pave way for more effective cancer therapies

Shifting towards precision medicine for type 2 diabetes dietary management

AI algorithms outperform the standard clinical risk model for predicting breast cancer risk

SickKids scientists shine light on the complex genetics that underlie blood pressure regulation

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority

Research sheds new light on the genetic architecture of bipolar disorder

Simplifying AI data analysis for scientists – as REPROCELL, IBM and STFC Hartree Centre successfully launch Pharmacology-AI platform

NCI launches new initiative to test new drug combinations that target specific tumor alterations

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Illinois Tech selected as enrollment site for NIH's landmark initiative to advance nutrition research

Markey one of 71 NCI designated cancer centers in the U.S.

Study examines the role of genetic variants across diverse ancestries in regulating gene expression

Study highlights the genetic basis of cognitive biases in decision making

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News